Market Tracker

02/19 8:34am ET

ResMed Inc (NYSE:RMD)

93.81
Delayed Data
As of Feb 16
 -0.38 / -0.40%
Today’s Change
67.04
Today|||52-Week Range
104.78
+10.77%
Year-to-Date
Haemonetics' (HAE) Q3 Earnings Top Estimates, EPS View Up
Feb 07 / Zacks.com - Paid Partner Content
Align Technology Banks on Global Growth, Competition Rife
Feb 06 / Zacks.com - Paid Partner Content
LabCorp (LH) Q4 Earnings Beat Estimates, '18 View Promising
Feb 06 / Zacks.com - Paid Partner Content
Genomic Health (GHDX) Oncotype DX GPS Test Results Positive
Feb 06 / Zacks.com - Paid Partner Content
Phibro Animal (PAHC) Beats on Q2 Earnings, Raises Guidance
Feb 06 / Zacks.com - Paid Partner Content
IDEXX Laboratories Strong on CAG Business Amid Currency Woes
Feb 06 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close94.19
Today’s open93.91
Day’s range93.76 - 95.15
Volume810,948
Average volume (3 months)703,638
Market cap$13.3B
Data as of 4:02pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)-3.61%
Earnings growth (this year)+27.10%
Earnings growth (next 5 years)+15.20%
Revenue growth (last year)+12.40%
P/E ratio47.1
Price/Sales5.37
Price/Book6.80

Competitors

 Today’s
change
Today’s
% change
VARVarian Medical Syste...-0.61-0.50%
LIVNLivaNova PLC+0.04+0.05%
NVRONevro Corp+0.30+0.38%
IRTCIrhythm Technologies...+1.76+2.89%
Data as of 4:02pm ET, 02/16/2018

Financials

Next reporting dateApril 26, 2018
EPS forecast (this quarter)$0.81
Annual revenue (last year)$2.1B
Annual profit (last year)$342.3M
Net profit margin16.56%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
Mick Farrell
President &
Chief Operating Officer
Rob Douglas
Corporate headquarters
San Diego, California

Forecasts